BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15991075)

  • 1. Identification and
    Hosseini Nami A; Kabiri M; Zafarghandi Motlagh F; Shirzadeh T; Bagherian H; Zeinali R; Karimi A; Zeinali S
    Ther Adv Respir Dis; 2024; 18():17534666241253990. PubMed ID: 38904297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Consequences of CFTR Interactions in Cystic Fibrosis.
    Ramananda Y; Naren AP; Arora K
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic Fibrosis, CFTR, and Colorectal Cancer.
    Scott P; Anderson K; Singhania M; Cormier R
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse.
    Philp AR; Riquelme TT; Millar-Büchner P; González R; Sepúlveda FV; Cid LP; Flores CA
    Sci Rep; 2018 Jun; 8(1):9320. PubMed ID: 29915289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine.
    Butnariu LI; Țarcă E; Cojocaru E; Rusu C; Moisă ȘM; Leon Constantin MM; Gorduza EV; Trandafir LM
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion.
    Lefferts JW; Kroes S; Smith MB; Niemöller PJ; Nieuwenhuijze NDA; Sonneveld van Kooten HN; van der Ent CK; Beekman JM; van Beuningen SFB
    Commun Biol; 2024 Mar; 7(1):319. PubMed ID: 38480810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients.
    Zhou YH; Gallins PJ; Pace RG; Dang H; Aksit MA; Blue EE; Buckingham KJ; Collaco JM; Faino AV; Gordon WW; Hetrick KN; Ling H; Liu W; Onchiri FM; Pagel K; Pugh EW; Raraigh KS; Rosenfeld M; Sun Q; Wen J; Li Y; Corvol H; Strug LJ; Bamshad MJ; Blackman SM; Cutting GR; Gibson RL; O'Neal WK; Wright FA; Knowles MR
    Am J Respir Crit Care Med; 2023 May; 207(10):1324-1333. PubMed ID: 36921087
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver disease in cystic fibrosis: an update.
    Parisi GF; Di Dio G; Franzonello C; Gennaro A; Rotolo N; Lionetti E; Leonardi S
    Hepat Mon; 2013 Aug; 13(8):e11215. PubMed ID: 24171010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis management in pediatric population-from clinical features to personalized therapy.
    Azoicai AN; Lupu A; Trandafir LM; Alexoae MM; Alecsa M; Starcea IM; Cuciureanu M; Knieling A; Salaru DL; Hanganu E; Mocanu A; Lupu VV; Ioniuc I
    Front Pediatr; 2024; 12():1393193. PubMed ID: 38798310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Qatari siblings with cystic fibrosis and apparent mineralocorticoid excess.
    Zahraldin K; Janahi IA; Ben-Omran T; Alsulaiman R; Hamad B; Imam A
    Ann Thorac Med; 2015; 10(1):69-72. PubMed ID: 25593612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of cystic fibrosis.
    Pollard HB; Eidelman O; Jacobson KA; Srivastava M
    Mol Interv; 2001 Apr; 1(1):54-63. PubMed ID: 14993338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in ion channel phenotype and function between humans and animal models.
    Tanner MR; Beeton C
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):43-64. PubMed ID: 28930537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifier genes and the plasticity of genetic networks in mice.
    Hamilton BA; Yu BD
    PLoS Genet; 2012; 8(4):e1002644. PubMed ID: 22511884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of cystic fibrosis.
    Gallati S
    Semin Respir Crit Care Med; 2003 Dec; 24(6):629-38. PubMed ID: 16088579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?
    Büscher R; Grasemann H
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):65-77. PubMed ID: 17033796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cystic fibrosis modifying genes].
    Knauer N; Ratjen F; Grasemann H
    Pneumologie; 2005 Jun; 59(6):395-404. PubMed ID: 15991075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiologic study of the cystic fibrosis gene in the Champagne-Ardenne region].
    Clavel C; Pennaforte F; Pigeon F; Mozelle M; Boutterin MC; Duval-Binninger I; F-erec C; Birembaut P
    Ann Biol Clin (Paris); 1996; 54(2):67-74. PubMed ID: 8763629
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.